Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

doi:10.4254/wjh.v9.i15.697

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8726)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

701

WORD

351

HTML

3208

Tables (1-3)

282

Sum=4542

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

584

Download

1066

Sum=1650

Publishing Process of This Article

Item

Count

Browse

1037

Download

1497

Sum=2534

May 28, 2017 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. May 28, 2017; 9(15): 697-703
Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.697

Table 3 Immunosuppressive drugs and metabolic side effects affecting post-liver transplantation cardiovascular risk[33]

Drug	Group	Side effects
Corticosteroids		Dyslipidemia ++
		AHT +++
		DM +++
		Renal impairment -
Mycophenolate mofetil	De novo purine synthesis inhibitor	Dyslipidemia -
		AHT -
		DM -
		Renal impairment -
Cyclosporine	Calcineurin inhibitors	Dyslipidemia ++
Tacrolimus		AHT +++
		DM ++
		Renal impairment ++
Sirolimus	mTOR inhibitors	Dyslipidemia +++
Everolimus		AHT -
		DM -
		Renal impairment -

(+): Positive association; (-): No association; AHT: Arterial Hypertension; DM: Diabetes mellitus.

Citation: Sanchez-Torrijos Y, Ampuero J, Romero-Gómez M. Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World J Hepatol 2017; 9(15): 697-703
URL: https://www.wjgnet.com/1948-5182/full/v9/i15/697.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i15.697